$VCYT 3 SEC Filings

Filed On	Filing
25 Mar 2026	Form 3: Haas Kevin Richard, Chief Dev and Tech Officer No securities owned
04 Sep 2024	Form 3: Miller Thomas F., Director No securities owned
04 Sep 2024	Form 3: Shafer David Brent, Director No securities owned
04 Oct 2023	Form 3: Febbo Phillip G., Chief Scientific & Med Officer No securities owned
06 Sep 2023	Form 3: Leite John, Chief Commercial Officer-CLIA Holds 41,465 shares of Common Stock
11 Aug 2022	Form 3: Barr Eliav, Director No securities owned
03 Mar 2022	Form 3: Wygant Jonathan, VP, Chief Accounting Officer Holds 12,000 shares of Common Stock
02 Mar 2022	Form 3: McGuire Annie, SVP, General Counsel No securities owned
13 Jan 2022	Form 3: Nova Tina Susan, President, CLIA U.S. Holds 30,000 shares of Common Stock
20 Jul 2021	Form 3: Chambers Rebecca, Chief Financial Officer No securities owned
03 Jun 2021	Form 3: Stapley Marc, Chief Executive Officer No securities owned
05 Apr 2021	Form 3: Alley Beverly Jane, VP, Corporate Controller Holds 7,500 shares of Common Stock
23 Mar 2021	Form 3: Bhanji Muna, Director No securities owned
06 Aug 2020	Form 3: Holstein Jens, Director No securities owned
04 Aug 2020	Form 3: Erlinger Iii James H, EVP, General Counsel No securities owned
01 Jul 2019	Form 3: Hanna John Walter Jr, Chief Commercial Officer Holds 65,357 shares of Common Stock
01 Jul 2019	Form 3: Ho Mark, Principal Accounting Officer Holds 21,187 shares of Common Stock
04 Mar 2019	Form 3: Kennedy Giulia C, Chief Scientific & Med Officer Holds 9,400 shares of Common Stock
13 Dec 2016	Form 3: Gordon Kevin K, Director No securities owned
08 Dec 2016	Form 3: Kennedy Keith, Chief Financial Officer No securities owned

Comments